64 filings
Page 3 of 4
8-K
9os38tholnq9u
1 Mar 22
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
4:09pm
8-K
u9kiwr
15 Feb 22
HOOKIPA and Gilead Amend Collaboration and License Agreement to Develop Immunotherapies Against HIV
4:18pm
8-K
1sexvb7 xetoofs
1 Feb 22
Departure of Directors or Certain Officers
5:30pm
8-K
kozpv2 lw6
10 Nov 21
HOOKIPA Pharma Reports Third Quarter 2021 Financial Results and Recent Highlights
6:46am
8-K
zkiq6arm5f27 e6iv
9 Nov 21
HOOKIPA advances HB-200 program to Phase 2 and prioritizes oncology portfolio based on clinical data updates across its novel arenaviral platform
4:04pm
8-K
1ie8x 9da91tnys
12 Aug 21
HOOKIPA Pharma Reports Second Quarter 2021 Financial Results and Recent Highlights
4:01pm
8-K
ozxu gqjhm
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
4sm1q6te 4y3e9j5l
12 May 21
HOOKIPA Pharma Reports First Quarter 2021 Financial Results and Recent Highlights
7:21am
8-K
o5lo5s7rmoo3 ncpmbij
20 Apr 21
Departure of Directors or Certain Officers
12:00am
8-K
t6t3y vkbtrv8
18 Mar 21
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
7:14am
8-K
ats7xwr9g5p8o7dq03
11 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
6x19tiqo
10 Dec 20
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock
12:00am
8-K
0hc07z16vukr uzq
7 Dec 20
Regulation FD Disclosure
6:09am
8-K
sdel3szw
30 Nov 20
HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101
6:11am
8-K
y30x9m1j
12 Nov 20
HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
7:38am
8-K
fqmzh
19 Oct 20
Departure of Directors or Certain Officers
4:18pm
8-K
x6qb6gqkl9j6o
13 Aug 20
HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
7:23am
8-K
lv8uqoub4u
22 Jun 20
HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB-101
7:24am
8-K
t2m t6tu8rs6mx7ygd3a
19 Jun 20
HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer
8:51am
8-K
89xj8gn dxn
14 May 20
HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update
7:25am